However, future studies should further explore the functional relevance of cell type-specific differential splicing in FLT3-ITD+/NPM1+ AML cells in order to determine their impact on response to treatment and usefulness as novel therapeutic targets. Here, NPM1 is linked to acute myeloid leukemia.